Latest On Denali Therapeutics Inc (DNLI):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-08 23:08 EST | News | Denali Therapeutics GAAP EPS of -$0.80 misses by $0.10, revenue of $35.14M beats by $5.26M | N/A |  |
| 2023-04-17 20:53 EST | News | Denali Therapeutics: Pioneering The Neurodegenerative Space With Blood-Brain Barrier Innovations | N/A | |
| 2023-04-12 16:39 EST | News | Biogen licenses amyloid beta-related program from Denali | N/A | |
| 2023-02-28 03:57 EST | News | Denali Therapeutics GAAP EPS of -$0.75 beats by $0.03, revenue of $10.28M misses by $1.01M | N/A | |
| 2023-01-25 16:03 EST | News | Denali to get $25M milestone as Sanofi begins dosing in multiple sclerosis study | N/A | |
| 2023-01-16 20:10 EST | News | Denali: Need Patient Data To Justify That High Valuation | N/A | |
| 2022-11-04 01:50 EST | News | Denali Therapeutics GAAP EPS of -$0.84 misses by $0.06 | N/A | |
| 2022-11-02 16:25 EST | News | Denali upgraded to buy at BTIG on platform to deliver therapies across blood-brain barrier | N/A | |
| 2022-10-29 05:32 EST | News | Denali Therapeutics: Two Shots On Goal For Parkinson's Disease Treatment | N/A | |
| 2022-10-20 15:17 EST | News | Denali Therapeutics prices $275M stock offering | N/A | |
| 2022-10-18 18:05 EST | News | Denali Therapeutics proposes $250M stock offering; shares down 6% post market | N/A | |
| 2022-10-11 01:17 EST | News | Biogen, Denali begin dosing in late-stage trial of Parkinson's candidate BIIB122 | N/A | |
| 2022-08-09 01:32 EST | News | Denali Therapeutics GAAP EPS of -$0.48 beats by $0.04, revenue of $52.48M beats by $7.82M | N/A | |
| 2022-06-23 11:35 EST | News | Denali Therapeutics initiated at buy at Berenberg on getting drugs directly into brain | N/A | |
| 2022-05-31 21:52 EST | News | Denali Therapeutics, Biogen begin phase 2 study of BIIB122 to treat Parkinson’s disease | N/A | |
| 2022-05-06 02:10 EST | News | Denali Therapeutics GAAP EPS of -$0.53 misses by $0.03, revenue of $42.14M beats by $8.82M | N/A | |
| 2022-05-02 19:07 EST | News | Denali to get $40M as partner Sanofi begins dosing in mid-stage study of ALS drug | N/A | |
| 2022-03-17 07:13 EST | News | Denali Therapeutics (DNLI) Presents At Oppenheimer 32nd Annual Healthcare Virtual Conference - Slideshow | N/A | |
| 2022-03-15 22:18 EST | News | Denali adds CFO role to chief operating officer as former CFO joins board | N/A | |
| 2022-03-09 22:43 EST | News | Denali begins dosing in phase 1/2 trial of DNL593 to treat frontotemporal dementia | N/A | |
| 2022-03-01 05:42 EST | News | Denali Therapeutics GAAP EPS of -$0.62 misses by $0.16, revenue of $12.51M misses by $32.31M | N/A | |
| 2022-02-26 02:21 EST | News | Denali Therapeutics: 2021 Was Mostly Bad Luck And Trouble | N/A | |
| 2022-01-13 14:17 EST | News | Denali Therapeutics falls on FDA clinical hold for Alzheimer’s candidate | N/A | |
| 2021-12-19 10:49 EST | News | Alnylam, Crispr Therapeutics among Goldman's biopharma M&A targets for 2022 | N/A | |
| 2021-11-17 16:13 EST | News | Takeda Pharma exercises option to co-develop and co-commercialize DNL593 | N/A | |
| 2021-10-22 06:07 EST | News | Warning: DNLI is at high risk of performing badly | N/A | |
| 2021-10-12 04:56 EST | News | As Supernus acquires Adamas, other Parkinson's players mixed on the day | N/A | |
| 2021-10-07 08:57 EST | News | Denali/Sanofi ALS candidate granted FDA Fast Track status | N/A | |
| 2021-09-29 13:59 EST | News | Warning: DNLI has been downgraded to Very Bearish | N/A | |
| 2021-09-27 16:22 EST | News | Denali Therapeutics names Katie Peng as chief commercial officer | N/A | |
| 2021-09-21 16:38 EST | News | Denali Therapeutics (DNLI) Presents At H.C. Wainwright 23rd Annual Global Investment Conference - Slideshow | N/A | |
| 2021-09-21 16:35 EST | News | Oppenheimer initiates Denali Therapeutics with outperform; sees ~70% upside | N/A | |
| 2021-09-10 20:06 EST | News | Denali Therapeutics: Another Near-Term Capital Gain Prospect Market-Makers See As Underpriced | N/A | |
| 2021-09-09 23:52 EST | News | Denali Therapeutics launches Phase 1b DNL343 study in amyotrophic lateral sclerosis | N/A | |
| 2021-08-05 03:32 EST | News | Denali Therapeutics EPS misses by $0.11, misses on revenue | N/A | |
| 2021-07-26 15:17 EST | News | Denali Therapeutics reports interim DNL310 data in mid-stage hunter syndrome study | N/A | |
| 2021-07-21 06:00 EST | News | Denali Therapeutics (DNLI) Presents At UBS 2021 Global Healthcare Virtual Conference - Slideshow | N/A | |
| 2021-07-21 05:50 EST | News | Denali Therapeutics (DNLI ) Presents At 2021 Jefferies Virtual Healthcare Conference - Slideshow | N/A | |
| 2021-07-21 05:41 EST | News | Denali Therapeutics (DNLI) Presents At Goldman Sachs 42nd Annual Global Healthcare Conference - Slideshow | N/A | |
| 2021-05-03 21:26 EST | News | Denali presents positive results from early-stage studies of BIIB122/DNL151 in Parkinson’s disease | N/A | |
| 2021-05-03 21:25 EST | News | Denali Therapeutics EPS misses by $0.21, misses on revenue | N/A | |
| 2021-03-26 07:58 EST | News | Denali Is Getting To Be More And More Interesting | N/A | |
| 2021-03-14 13:39 EST | News | Denali Therapeutics (DNLI) Presents At HC Wainwright Global Life Sciences Conference | N/A | |
| 2021-03-12 02:43 EST | News | Denali nabs FDA’s Fast Track status for DNL310 in Hunter syndrome | N/A | |
| 2021-03-09 15:47 EST | News | Centogene reaches a milestone in Parkinson's Disease study | N/A | |
| 2021-03-02 07:34 EST | Analyst Rating | The Analyst Target Price has increased from $80.44 to $81. | Buy | |
| 2021-03-01 07:36 EST | Earnings Estimate | An EPS average of -$2.02 is estimated for the 2022 year. | Sell | |
| 2021-03-01 07:36 EST | Earnings Estimate | An EPS average of -$0.41 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-03-01 07:36 EST | Analyst Rating | The Analyst Target Price has increased from $78.78 to $80.44. | Buy | |
| 2021-02-28 03:28 EST | Financials | Company financials have been released. | Neutral | |
About Denali Therapeutics Inc (DNLI):
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidates, including DNL201 that has completed Phase 1b clinical trials and DNL151, which are in Phase 1 and Phase 1b clinical trials for Parkinson's disease. It is also developing receptor interacting serine/threonine protein kinase 1 (RIPK1) product candidates, such as DNL747, a selective and brain-penetrant small molecule RIPK1 inhibitor product candidate that is in Phase 1b clinical trial for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). In addition, the company develops enzyme transport vehicle: iduronate 2-sulfatase, an enzyme replacement therapy program for MPS II, a lysosomal storage disorder; antibody transport vehicle (ATV): alpha-synuclein (aSyn) program, a protein that spreads throughout the brain in Parkinson's disease; ATV: triggering receptor expressed in myeloid cells 2, a therapeutic candidate designed to rescue microglial function in Alzheimer's disease; and ATV: Tau, a therapeutic targeting the spreading of Tau. Denali Therapeutics Inc. has collaboration agreement with Takeda Pharmaceutical Company and Genentech, Inc., Sanofi, F-star Gamma Limited, F-star Biotechnologische Forschungs-Und Entwicklungsges M.B.H, F-star Biotechnology Limited, SIRION Biotech GmbH, Genzyme Corporation, Harvard University, the Michael J. Fox Foundation, Centogene, and MedGenome Labs Private Ltd; and a research and option agreement with Secarna Pharmaceuticals GmbH & Co. KG. to develop antisense therapies in the field of neurodegenerative diseases. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California.
General
- Name Denali Therapeutics Inc
- Symbol DNLI
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 291
- Fiscal Year EndDecember
- IPO Date2017-12-08
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.denalitherapeutics.com
View More
Valuation
- Trailing PE 94.44
- Price/Sales (Trailing 12 Mt.) 21.72
- Price/Book (Most Recent Quarter) 6.8
- Enterprise Value Revenue 19.14
- Enterprise Value EBITDA 90.19
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.34
- Next Year EPS Estimate -$2.00
- Next Quarter EPS Estimate -$0.39
- Profit Margin 21%
- Operating Margin 19%
- Return on Assets 4%
- Return on Equity 9%
- Revenue 335.66 million
- Earnings Per Share $0.63
- Revenue Per Share $3.08
- Gross Profit 123.04 million
- Quarterly Earnings Growth 6681.1%
View More
Highlights
- Market Capitalization 7.2 billion
- EBITDA 71.25 million
- PE Ratio -8.34
- Analyst Target Price $81
- Book Value Per Share $9.55
View More
Share Statistics
- Shares Outstanding 119.29 million
- Shares Float 79.59 million
- % Held by Insiders 1761%
- % Held by Institutions 78.64%
- Shares Short 6.7 million
- Shares Short Prior Month 6.97 million
- Short Ratio 10.85
- Short % of Float 9%
- Short % of Shares Outstanding 6%
View More
Technicals
- Beta 2.03
- 52 Week High $93.94
- 52 Week Low $15.72
- 50 Day Moving Average 65.96
- 200 Day Moving Average 59.4
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Denali Therapeutics Inc (DNLI) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Denali Therapeutics Inc (DNLI) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-25 | $N/A | $1.91 | -$0.60 | 417.01% |
| 2020-09-30 | 2020-11-05 | $N/A | -$0.54 | $2.20 | -124.6% |
| 2020-06-30 | 2020-08-07 | $N/A | -$0.56 | -$0.61 | 8.2% |
| 2020-03-31 | 2020-05-07 | $3.6 million | -$0.55 | -$0.57 | 3.25% |
| 2019-12-31 | 2020-02-27 | $4.67 million | -$0.56 | -$0.63 | 11.11% |
| 2019-09-30 | 2019-11-06 | $13.6 million | -$0.48 | -$0.55 | 13.14% |
| 2019-06-30 | 2019-08-06 | $4.2 million | -$0.61 | -$0.46 | -33.68% |
| 2019-03-31 | 2019-05-08 | $4.21 million | -$0.41 | -$0.44 | 6.82% |
| 2018-12-31 | 2019-03-12 | $125.68 million | $0.79 | -$0.32 | 345.34% |
| 2018-09-30 | 2018-11-08 | $1.2 million | -$0.38 | -$0.29 | -31.94% |
| 2018-06-30 | 2018-08-09 | $1.65 million | -$0.59 | -$0.22 | -164.93% |
| 2018-03-31 | 2018-05-11 | $641000 | -$0.26 | $0.30 | -185.3% |
| 2017-12-31 | 2018-03-19 | $N/A | -$0.74 | -$0.29 | -152.04% |
Denali Therapeutics Inc (DNLI) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | 51.02 million | 193.38 million |
| Income Before Tax | N/A | N/A | N/A | -56.9 million | -53.95 million |
| Selling General Administrative | N/A | N/A | N/A | 12.56 million | 10.88 million |
| Gross Profit | N/A | N/A | N/A | N/A | 146.5 million |
| Ebit | N/A | N/A | N/A | -57.86 million | -57.76 million |
| Operating Income | N/A | N/A | N/A | -59.97 million | -57.76 million |
| Income Tax Expense | 823000 | 56000 | 79000 | -135000 | 75000 |
| Total Revenue | N/A | N/A | N/A | 3.6 million | 4.67 million |
| Cost of Revenue | N/A | N/A | N/A | N/A | -141.83 million |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | 3.81 million |
| Net Income From Continuing Operations | N/A | N/A | N/A | -56.76 million | -54.03 million |
| Net Income Applicable to Common Shares | 244.89 million | -58.23 million | -58.76 million | -56.76 million | -54.03 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | 45.16 million | 52.34 million |
| Change to Liabilities | 36.47 million | -6.03 million | -3.36 million | -2.92 million | -2.02 million |
| Total Cash Flow from Investing Activities | -212.12 million | -30.41 million | -13.33 million | 42.39 million | 49.49 million |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | 2.03 million | 679000 |
| Change to Operating Activities | 7.12 million | 8.5 million | -6.92 million | 740000 | 7.87 million |
| Change in Cash | N/A | N/A | N/A | -3.22 million | 19.74 million |
| Total Cash from Operating Activities | 86000 | -43.36 million | -54.49 million | -47.64 million | -30.44 million |
| Depreciation | N/A | N/A | N/A | 2.06 million | 1.89 million |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | 632000 | -632000 | N/A | N/A | N/A |
| Change to Net Income | 12.57 million | 10.78 million | 10.45 million | 6.51 million | 8.08 million |
| Capital Expenditures | N/A | N/A | N/A | 2.77 million | 2.85 million |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | N/A | 150.55 million | 158.34 million |
| Total Stockholder Equity | N/A | N/A | N/A | 545.31 million | 394.89 million |
| Other Current Liabilities | 23.48 million | 72.87 million | N/A | N/A | 18.74 million |
| Total Assets | N/A | N/A | N/A | 695.87 million | 553.23 million |
| Common Stock | 1.15 billion | 1.52 million | 502.17 million | 1.38 million | 1.29 million |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | N/A | -599.3 million | N/A | -482.31 million | -425.55 million |
| Other Liabilities | 317.88 million | 16.94 million | 20.09 million | 35.13 million | 44.13 million |
| Other Assets | 2.46 million | 3.86 million | 3.77 million | 2.32 million | 2.66 million |
| Cash | N/A | N/A | N/A | 207.54 million | 79.45 million |
| Total Current Liabilities | 71.7 million | 105.41 million | N/A | 47.64 million | 45.34 million |
| Other Stockholder Equity | N/A | 11000 | N/A | 835000 | 350000 |
| Property, Plant & Equipment | 73.46 million | 75.24 million | 76.93 million | 79.08 million | 80.66 million |
| Total Current Assets | 1.5 billion | 970.87 million | N/A | 604.79 million | 430.03 million |
| Long Term Investments | N/A | N/A | N/A | 9.68 million | 39.89 million |
| Net Tangible Assets | 1.15 billion | 882.55 million | 502.17 million | 545.31 million | 394.89 million |
| Short Term Investments | N/A | N/A | N/A | 379.71 million | 335.91 million |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | 1.07 million | 2.81 million | N/A | 2.32 million | 2.59 million |
Denali Therapeutics Inc (DNLI) Chart:
Denali Therapeutics Inc (DNLI) News:
Below you will find a list of latest news for Denali Therapeutics Inc (DNLI) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Denali Therapeutics Inc (DNLI) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-19 | 2.5 | 0 | CALL | 0 | 0 | 600.36 | TRUE | 0 | 0 |
| 2025-12-19 | 5 | 0 | CALL | 0 | 0 | 384.14 | TRUE | 0 | 0 |
| 2025-12-19 | 7.5 | 12.79 | CALL | 0 | 2 | 262.32 | TRUE | 0 | 0 |
| 2025-12-19 | 10 | 10.36 | CALL | 0 | 14 | 176.87 | TRUE | 0 | 0 |
| 2025-12-19 | 12.5 | 5.1 | CALL | 3 | 32 | 184.15 | TRUE | -0.6 | -0.11 |
| 2025-12-19 | 15 | 4.56 | CALL | 0 | 53 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 17.5 | 2.05 | CALL | 0 | 51 | 185.86 | FALSE | 0 | 0 |
| 2025-12-19 | 20 | 2.1 | CALL | 0 | 56 | 296.6 | FALSE | 0 | 0 |
| 2025-12-19 | 22.5 | 0.25 | CALL | 0 | 41 | 267.47 | FALSE | 0 | 0 |
| 2025-12-19 | 25 | 0.19 | CALL | 0 | 6 | 416.55 | FALSE | 0 | 0 |
| 2025-12-19 | 30 | 0.55 | CALL | 0 | 2 | 497.05 | FALSE | 0 | 0 |
| 2025-12-19 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 5 | 0 | PUT | 0 | 0 | 1288.54 | FALSE | 0 | 0 |
| 2025-12-19 | 7.5 | 0 | PUT | 0 | 0 | 897.15 | FALSE | 0 | 0 |
| 2025-12-19 | 10 | 0.9 | PUT | 0 | 1 | 456.12 | FALSE | 0 | 0 |
| 2025-12-19 | 12.5 | 0.15 | PUT | 3 | 95 | 166.04 | FALSE | 0.1 | 2 |
| 2025-12-19 | 15 | 0.01 | PUT | 0 | 17 | 123.55 | FALSE | 0 | 0 |
| 2025-12-19 | 17.5 | 0.52 | PUT | 2 | 579 | 44.61 | TRUE | 0.07 | 0.16 |
| 2025-12-19 | 20 | 1.35 | PUT | 0 | 8 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 22.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 25 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 30 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 2.5 | 0 | CALL | 0 | 0 | 328.27 | TRUE | 0 | 0 |
| 2026-01-16 | 5 | 0 | CALL | 0 | 0 | 207.26 | TRUE | 0 | 0 |
| 2026-01-16 | 7.5 | 0 | CALL | 0 | 0 | 139.99 | TRUE | 0 | 0 |
| 2026-01-16 | 10 | 10.48 | CALL | 0 | 2 | 118.24 | TRUE | 0 | 0 |
| 2026-01-16 | 12.5 | 0 | CALL | 0 | 0 | 88.93 | TRUE | 0 | 0 |
| 2026-01-16 | 15 | 2.77 | CALL | 60 | 1 | 58.53 | TRUE | 2.77 | 0 |
| 2026-01-16 | 17.5 | 1.5 | CALL | 0 | 9 | 72.72 | FALSE | 0 | 0 |
| 2026-01-16 | 20 | 1.05 | CALL | 0 | 23 | 159.74 | FALSE | 0 | 0 |
| 2026-01-16 | 22.5 | 0.05 | CALL | 0 | 14 | 94.25 | FALSE | 0 | 0 |
| 2026-01-16 | 25 | 0 | CALL | 0 | 0 | 198.1 | FALSE | 0 | 0 |
| 2026-01-16 | 30 | 0 | CALL | 0 | 0 | 233.74 | FALSE | 0 | 0 |
| 2026-01-16 | 35 | 0 | CALL | 0 | 0 | 263.07 | FALSE | 0 | 0 |
| 2026-01-16 | 2.5 | 0 | PUT | 0 | 0 | 1210.75 | FALSE | 0 | 0 |
| 2026-01-16 | 5 | 0 | PUT | 0 | 0 | 608.73 | FALSE | 0 | 0 |
| 2026-01-16 | 7.5 | 0 | PUT | 0 | 0 | 423.98 | FALSE | 0 | 0 |
| 2026-01-16 | 10 | 0 | PUT | 0 | 0 | 315.72 | FALSE | 0 | 0 |
| 2026-01-16 | 12.5 | 0.75 | PUT | 0 | 4 | 235.52 | FALSE | 0 | 0 |
| 2026-01-16 | 15 | 0.4 | PUT | 0 | 19 | 86.9 | FALSE | 0 | 0 |
| 2026-01-16 | 17.5 | 1.24 | PUT | 0 | 15 | 77.61 | TRUE | 0 | 0 |
| 2026-01-16 | 20 | 0 | PUT | 0 | 0 | 52.94 | TRUE | 0 | 0 |
| 2026-01-16 | 22.5 | 0 | PUT | 0 | 0 | 62.52 | TRUE | 0 | 0 |
| 2026-01-16 | 25 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 30 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 35 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-03-20 | 2.5 | 0 | CALL | 0 | 0 | 213.73 | TRUE | 0 | 0 |
| 2026-03-20 | 5 | 14 | CALL | 0 | 0 | 144.29 | TRUE | 0 | 0 |
| 2026-03-20 | 7.5 | 12 | CALL | 0 | 5 | 111.65 | TRUE | 0 | 0 |
| 2026-03-20 | 10 | 9 | CALL | 0 | 19 | 85.25 | TRUE | 0 | 0 |
| 2026-03-20 | 12.5 | 8.2 | CALL | 0 | 22 | 75.11 | TRUE | 0 | 0 |
| 2026-03-20 | 15 | 5.8 | CALL | 0 | 190 | 83.24 | TRUE | 0 | 0 |
| 2026-03-20 | 17.5 | 2.5 | CALL | 0 | 423 | 58.56 | FALSE | 0 | 0 |
| 2026-03-20 | 20 | 1.34 | CALL | 7 | 174 | 61.43 | FALSE | 1.34 | 0 |
| 2026-03-20 | 22.5 | 0.9 | CALL | 0 | 20 | 122.06 | FALSE | 0 | 0 |
| 2026-03-20 | 25 | 1 | CALL | 0 | 35 | 131.39 | FALSE | 0 | 0 |
| 2026-03-20 | 30 | 1.04 | CALL | 0 | 29 | 151.89 | FALSE | 0 | 0 |
| 2026-03-20 | 35 | 0.5 | CALL | 0 | 1 | 168.4 | FALSE | 0 | 0 |
| 2026-03-20 | 2.5 | 0 | PUT | 0 | 0 | 735.7 | FALSE | 0 | 0 |
| 2026-03-20 | 5 | 0 | PUT | 0 | 0 | 368.78 | FALSE | 0 | 0 |
| 2026-03-20 | 7.5 | 0 | PUT | 0 | 0 | 257.03 | FALSE | 0 | 0 |
| 2026-03-20 | 10 | 0.85 | PUT | 0 | 8 | 194.09 | FALSE | 0 | 0 |
| 2026-03-20 | 12.5 | 1 | PUT | 0 | 7 | 151.05 | FALSE | 0 | 0 |
| 2026-03-20 | 15 | 0.85 | PUT | 0 | 316 | 122.55 | FALSE | 0 | 0 |
| 2026-03-20 | 17.5 | 2 | PUT | 1 | 5 | 55.91 | TRUE | 2 | 0 |
| 2026-03-20 | 20 | 3.01 | PUT | 0 | 2 | 57.11 | TRUE | 0 | 0 |
| 2026-03-20 | 22.5 | 4 | PUT | 0 | 1 | 54.68 | TRUE | 0 | 0 |
| 2026-03-20 | 25 | 6 | PUT | 0 | 2 | 58.57 | TRUE | 0 | 0 |
| 2026-03-20 | 30 | 0 | PUT | 0 | 0 | 71.65 | TRUE | 0 | 0 |
| 2026-03-20 | 35 | 0 | PUT | 0 | 0 | 75.73 | TRUE | 0 | 0 |
| 2026-06-18 | 2.5 | 0 | CALL | 0 | 0 | 185.05 | TRUE | 0 | 0 |
| 2026-06-18 | 5 | 0 | CALL | 0 | 0 | 125.62 | TRUE | 0 | 0 |
| 2026-06-18 | 7.5 | 0 | CALL | 0 | 0 | 96.26 | TRUE | 0 | 0 |
| 2026-06-18 | 10 | 7.9 | CALL | 0 | 6 | 83.23 | TRUE | 0 | 0 |
| 2026-06-18 | 12.5 | 6.68 | CALL | 0 | 14 | 77.56 | TRUE | 0 | 0 |
| 2026-06-18 | 15 | 4.6 | CALL | 14 | 2 | 68.01 | TRUE | -0.75 | -0.14 |
| 2026-06-18 | 17.5 | 3.6 | CALL | 5 | 16 | 71.36 | FALSE | -0.8 | -0.18 |
| 2026-06-18 | 20 | 2.65 | CALL | 14 | 238 | 69.87 | FALSE | -0.1 | -0.04 |
| 2026-06-18 | 22.5 | 2.3 | CALL | 0 | 37 | 75.25 | FALSE | 0 | 0 |
| 2026-06-18 | 25 | 2.14 | CALL | 0 | 2 | 117.37 | FALSE | 0 | 0 |
| 2026-06-18 | 30 | 1.35 | CALL | 0 | 10 | 108.09 | FALSE | 0 | 0 |
| 2026-06-18 | 35 | 1 | CALL | 0 | 1 | 129.55 | FALSE | 0 | 0 |
| 2026-06-18 | 2.5 | 0 | PUT | 0 | 0 | 538.23 | FALSE | 0 | 0 |
| 2026-06-18 | 5 | 0 | PUT | 0 | 0 | 272.37 | FALSE | 0 | 0 |
| 2026-06-18 | 7.5 | 0 | PUT | 0 | 0 | 196.89 | FALSE | 0 | 0 |
| 2026-06-18 | 10 | 0.9 | PUT | 0 | 2 | 154.17 | FALSE | 0 | 0 |
| 2026-06-18 | 12.5 | 0 | PUT | 0 | 0 | 129.06 | FALSE | 0 | 0 |
| 2026-06-18 | 15 | 2 | PUT | 0 | 2 | 71.82 | FALSE | 0 | 0 |
| 2026-06-18 | 17.5 | 2.91 | PUT | 0 | 4 | 55.71 | TRUE | 0 | 0 |
| 2026-06-18 | 20 | 0 | PUT | 0 | 0 | 66.77 | TRUE | 0 | 0 |
| 2026-06-18 | 22.5 | 0 | PUT | 0 | 0 | 69.45 | TRUE | 0 | 0 |
| 2026-06-18 | 25 | 0 | PUT | 0 | 0 | 68.48 | TRUE | 0 | 0 |
| 2026-06-18 | 30 | 0 | PUT | 0 | 0 | 67.97 | TRUE | 0 | 0 |
| 2026-06-18 | 35 | 0 | PUT | 0 | 0 | 75.11 | TRUE | 0 | 0 |
Latest DNLI Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 1 | $22.09 |
| Jun 13, 2022 7:59 PM EST | 1 | $22.09 |
| Jun 13, 2022 7:59 PM EST | 1 | $22.09 |
| Jun 13, 2022 7:59 PM EST | 1 | $22.07 |
| Jun 13, 2022 7:59 PM EST | 8 | $22.1 |
Denali Therapeutics Inc (DNLI) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000089924320018024/0000899243-20-018024-index.htm |
| 2019-07-02 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1714899/000000000019010600/0000000000-19-010600-index.htm |
| 2019-08-16 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1714899/000000000019012569/0000000000-19-012569-index.htm |
| 2019-10-07 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1714899/000000000019014345/0000000000-19-014345-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1714899/000031506619000962/0000315066-19-000962-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1714899/000031506620000935/0000315066-20-000935-index.htm |
| 2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1714899/000083423720007999/0000834237-20-007999-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1714899/000083423720009090/0000834237-20-009090-index.htm |
| 2019-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000089924319010426/0000899243-19-010426-index.htm |
| 2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000089924320006252/0000899243-20-006252-index.htm |
| 2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000089924320015779/0000899243-20-015779-index.htm |
| 2020-06-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000089924320017498/0000899243-20-017498-index.htm |
| 2020-06-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000089924320018024/0000899243-20-018024-index.htm |
| 2020-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000089924320022430/0000899243-20-022430-index.htm |
| 2020-09-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000089924320026397/0000899243-20-026397-index.htm |
| 2019-02-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1714899/000093247119005274/0000932471-19-005274-index.htm |
| 2020-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1714899/000101143820000068/0001011438-20-000068-index.htm |
| 2019-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000101297519000551/0001012975-19-000551-index.htm |
| 2019-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000101297519000552/0001012975-19-000552-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1714899/000107261320000099/0001072613-20-000099-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1714899/000108887519000040/0001088875-19-000040-index.htm |
| 2020-01-16 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1714899/000108887520000010/0001088875-20-000010-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1714899/000110465920018678/0001104659-20-018678-index.htm |
| 2019-07-16 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1714899/000119312519194805/0001193125-19-194805-index.htm |
| 2019-09-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1714899/000119312519243097/0001193125-19-243097-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1714899/000119312520035592/0001193125-20-035592-index.htm |
| 2020-09-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1714899/000119312520256415/0001193125-20-256415-index.htm |
| 2018-11-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919118057788/0001209191-18-057788-index.htm |
| 2018-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919118057789/0001209191-18-057789-index.htm |
| 2018-11-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919118058797/0001209191-18-058797-index.htm |
| 2018-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919118059267/0001209191-18-059267-index.htm |
| 2018-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919118061329/0001209191-18-061329-index.htm |
| 2018-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919118061334/0001209191-18-061334-index.htm |
| 2018-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919118062266/0001209191-18-062266-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119002284/0001209191-19-002284-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119002289/0001209191-19-002289-index.htm |
| 2019-01-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119003443/0001209191-19-003443-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119007483/0001209191-19-007483-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119007484/0001209191-19-007484-index.htm |
| 2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119009061/0001209191-19-009061-index.htm |
| 2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119009068/0001209191-19-009068-index.htm |
| 2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119009072/0001209191-19-009072-index.htm |
| 2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119009077/0001209191-19-009077-index.htm |
| 2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119009482/0001209191-19-009482-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119016931/0001209191-19-016931-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119016941/0001209191-19-016941-index.htm |
| 2019-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119019213/0001209191-19-019213-index.htm |
| 2019-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119020068/0001209191-19-020068-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023478/0001209191-19-023478-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023479/0001209191-19-023479-index.htm |
| 2019-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023987/0001209191-19-023987-index.htm |
| 2019-04-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119024390/0001209191-19-024390-index.htm |
| 2019-05-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119027547/0001209191-19-027547-index.htm |
| 2019-05-10 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119029049/0001209191-19-029049-index.htm |
| 2019-05-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119029053/0001209191-19-029053-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119029432/0001209191-19-029432-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119033722/0001209191-19-033722-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119033735/0001209191-19-033735-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119033738/0001209191-19-033738-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119033740/0001209191-19-033740-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119033741/0001209191-19-033741-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119033743/0001209191-19-033743-index.htm |
| 2019-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119033967/0001209191-19-033967-index.htm |
| 2019-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119034076/0001209191-19-034076-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119034830/0001209191-19-034830-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119036499/0001209191-19-036499-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119036500/0001209191-19-036500-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119041176/0001209191-19-041176-index.htm |
| 2019-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119041708/0001209191-19-041708-index.htm |
| 2019-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119041710/0001209191-19-041710-index.htm |
| 2019-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119045394/0001209191-19-045394-index.htm |
| 2019-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119047184/0001209191-19-047184-index.htm |
| 2019-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119047185/0001209191-19-047185-index.htm |
| 2019-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119047187/0001209191-19-047187-index.htm |
| 2019-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119048640/0001209191-19-048640-index.htm |
| 2019-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119049178/0001209191-19-049178-index.htm |
| 2019-10-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119054152/0001209191-19-054152-index.htm |
| 2019-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119058147/0001209191-19-058147-index.htm |
| 2019-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119058172/0001209191-19-058172-index.htm |
| 2019-12-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119059302/0001209191-19-059302-index.htm |
| 2019-12-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119059343/0001209191-19-059343-index.htm |
| 2019-12-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919119061843/0001209191-19-061843-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120008922/0001209191-20-008922-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120008923/0001209191-20-008923-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120008924/0001209191-20-008924-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120008925/0001209191-20-008925-index.htm |
| 2020-04-01 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120022234/0001209191-20-022234-index.htm |
| 2020-04-01 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120022235/0001209191-20-022235-index.htm |
| 2020-04-01 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120022236/0001209191-20-022236-index.htm |
| 2020-04-01 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120022237/0001209191-20-022237-index.htm |
| 2020-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120022238/0001209191-20-022238-index.htm |
| 2020-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120022239/0001209191-20-022239-index.htm |
| 2020-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120022240/0001209191-20-022240-index.htm |
| 2020-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120022241/0001209191-20-022241-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120034764/0001209191-20-034764-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120034765/0001209191-20-034765-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120034766/0001209191-20-034766-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120034767/0001209191-20-034767-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120034768/0001209191-20-034768-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120034770/0001209191-20-034770-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120034771/0001209191-20-034771-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120034772/0001209191-20-034772-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120037764/0001209191-20-037764-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120037765/0001209191-20-037765-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120047792/0001209191-20-047792-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120047793/0001209191-20-047793-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120047794/0001209191-20-047794-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120047795/0001209191-20-047795-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120048173/0001209191-20-048173-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120048174/0001209191-20-048174-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120048175/0001209191-20-048175-index.htm |
| 2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120050357/0001209191-20-050357-index.htm |
| 2020-10-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120054727/0001209191-20-054727-index.htm |
| 2020-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1714899/000120919120057336/0001209191-20-057336-index.htm |
| 2020-01-27 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1714899/000162828020000564/0001628280-20-000564-index.htm |
| 2020-01-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000162828020000565/0001628280-20-000565-index.htm |
| 2020-01-29 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1714899/000162828020000680/0001628280-20-000680-index.htm |
| 2020-01-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000162828020000685/0001628280-20-000685-index.htm |
| 2018-11-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000171489918000020/0001714899-18-000020-index.htm |
| 2018-12-06 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1714899/000171489918000022/0001714899-18-000022-index.htm |
| 2019-01-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000171489919000002/0001714899-19-000002-index.htm |
| 2019-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000171489919000008/0001714899-19-000008-index.htm |
| 2019-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1714899/000171489919000015/0001714899-19-000015-index.htm |
| 2019-03-12 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1714899/000171489919000017/0001714899-19-000017-index.htm |
| 2019-03-12 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1714899/000171489919000018/0001714899-19-000018-index.htm |
| 2019-04-18 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1714899/000171489919000022/0001714899-19-000022-index.htm |
| 2019-04-18 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1714899/000171489919000023/0001714899-19-000023-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000171489919000031/0001714899-19-000031-index.htm |
| 2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1714899/000171489919000032/0001714899-19-000032-index.htm |
| 2019-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000171489919000038/0001714899-19-000038-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000171489919000041/0001714899-19-000041-index.htm |
| 2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1714899/000171489919000043/0001714899-19-000043-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000171489919000055/0001714899-19-000055-index.htm |
| 2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1714899/000171489919000056/0001714899-19-000056-index.htm |
| 2020-01-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000171489920000005/0001714899-20-000005-index.htm |
| 2020-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000171489920000025/0001714899-20-000025-index.htm |
| 2020-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1714899/000171489920000026/0001714899-20-000026-index.htm |
| 2020-02-28 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1714899/000171489920000027/0001714899-20-000027-index.htm |
| 2020-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000171489920000034/0001714899-20-000034-index.htm |
| 2020-04-22 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1714899/000171489920000041/0001714899-20-000041-index.htm |
| 2020-04-22 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1714899/000171489920000042/0001714899-20-000042-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000171489920000052/0001714899-20-000052-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1714899/000171489920000053/0001714899-20-000053-index.htm |
| 2020-06-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000171489920000060/0001714899-20-000060-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000171489920000075/0001714899-20-000075-index.htm |
| 2020-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000171489920000091/0001714899-20-000091-index.htm |
| 2020-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1714899/000171489920000092/0001714899-20-000092-index.htm |
| 2020-08-20 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000171489920000098/0001714899-20-000098-index.htm |
| 2020-08-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000171489920000099/0001714899-20-000099-index.htm |
| 2020-10-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000171489920000106/0001714899-20-000106-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1714899/000171489920000116/0001714899-20-000116-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1714899/000171489920000118/0001714899-20-000118-index.htm |
| 2018-11-19 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1714899/999999999718009037/9999999997-18-009037-index.htm |
| 2019-02-21 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1714899/999999999719000474/9999999997-19-000474-index.htm |
| 2019-03-25 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1714899/999999999719001939/9999999997-19-001939-index.htm |
Denali Therapeutics Inc (DNLI) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Denali Therapeutics Inc (DNLI). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1761%Institutional Ownership: 7864%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-02-01 | Carole Ho | Chief Medical Officer | Sell | 5,775.00 | 18.64 | 107,646.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119007484/0001209191-19-007484-index.htm |
| 2019-02-04 | Carole Ho | Chief Medical Officer | Sell | 769.00 | 19.11 | 14,695.59 | 0.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119007484/0001209191-19-007484-index.htm |
| 2019-02-05 | Carole Ho | Chief Medical Officer | Sell | 7,856.00 | 18.83 | 147,928.48 | 0.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119007484/0001209191-19-007484-index.htm |
| 2019-03-01 | Carole Ho | Chief Medical Officer | Sell | 1,951.00 | 22.92 | 44,716.92 | 0.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119016941/0001209191-19-016941-index.htm |
| 2019-03-04 | Carole Ho | Chief Medical Officer | Sell | 1,600.00 | 22.84 | 36,544.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119016941/0001209191-19-016941-index.htm |
| 2019-03-05 | Carole Ho | Chief Medical Officer | Sell | 5,862.00 | 21.96 | 128,729.52 | 0.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119016941/0001209191-19-016941-index.htm |
| 2019-03-14 | Carole Ho | Chief Medical Officer | Sell | 500.00 | 25.01 | 12,505.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119020068/0001209191-19-020068-index.htm |
| 2019-04-01 | Carole Ho | Chief Medical Officer | Sell | 5,775.00 | 23.91 | 138,080.25 | 0.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023479/0001209191-19-023479-index.htm |
| 2019-04-02 | Carole Ho | Chief Medical Officer | Sell | 3,335.00 | 25.15 | 83,875.25 | 0.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023479/0001209191-19-023479-index.htm |
| 2019-04-03 | Carole Ho | Chief Medical Officer | Sell | 600.00 | 26.81 | 16,086.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023479/0001209191-19-023479-index.htm |
| 2019-05-08 | Carole Ho | Chief Medical Officer | Sell | 2,613.00 | 23.50 | 61,405.50 | 0.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119029053/0001209191-19-029053-index.htm |
| 2019-05-09 | Carole Ho | Chief Medical Officer | Sell | 200.00 | 23.58 | 4,716.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119029053/0001209191-19-029053-index.htm |
| 2019-05-10 | Carole Ho | Chief Medical Officer | Sell | 2,546.00 | 22.17 | 56,444.82 | 0.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119029053/0001209191-19-029053-index.htm |
| 2019-06-10 | Carole Ho | Chief Medical Officer | Sell | 711.00 | 18.62 | 13,238.82 | 0.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119036499/0001209191-19-036499-index.htm |
| 2019-06-10 | Carole Ho | Chief Medical Officer | Sell | 3,906.00 | 18.81 | 73,471.86 | 0.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119036499/0001209191-19-036499-index.htm |
| 2019-12-23 | Carole Ho | Chief Medical Officer | Sell | 3,464.00 | 20.01 | 69,314.64 | 0.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119061843/0001209191-19-061843-index.htm |
| 2019-08-20 | Steve E. Krognes | CFO and Treasurer | Buy | 5,643.00 | 1,005,643.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119047184/0001209191-19-047184-index.htm | ||
| 2020-03-30 | Steve E. Krognes | CFO and Treasurer | Sell | 1,428.00 | 19.48 | 27,817.44 | 1,006,488.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919120022241/0001209191-20-022241-index.htm |
| 2020-08-20 | Steve E. Krognes | CFO and Treasurer | Buy | 5,643.00 | 1,008,465.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919120048173/0001209191-20-048173-index.htm | ||
| 2019-05-10 | Carole Ho | Chief Medical Officer | Sell | 3,316.00 | 22.16 | 73,482.56 | 103,806.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119029053/0001209191-19-029053-index.htm |
| 2019-05-09 | Carole Ho | Chief Medical Officer | Sell | 200.00 | 23.60 | 4,720.00 | 107,122.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119029053/0001209191-19-029053-index.htm |
| 2019-05-09 | Carole Ho | Chief Medical Officer | Sell | 3,010.00 | 22.83 | 68,718.30 | 107,322.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119029053/0001209191-19-029053-index.htm |
| 2019-05-08 | Carole Ho | Chief Medical Officer | Sell | 3,162.00 | 23.51 | 74,338.62 | 110,332.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119029053/0001209191-19-029053-index.htm |
| 2019-04-04 | Carole Ho | Chief Medical Officer | Sell | 1,433.00 | 27.00 | 38,691.00 | 113,494.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023987/0001209191-19-023987-index.htm |
| 2019-04-04 | Carole Ho | Chief Medical Officer | Sell | 8,155.00 | 26.24 | 213,987.20 | 114,927.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023987/0001209191-19-023987-index.htm |
| 2020-08-12 | DOUGLAS K BRATTON | 10% Share Holder | Sell | 1,443,247.00 | 31.65 | 45,678,767.55 | 12,201,634.00 | https://www.sec.gov/Archives/edgar/data/1714899/000089924320022430/0000899243-20-022430-index.htm |
| 2019-04-03 | Carole Ho | Chief Medical Officer | Sell | 900.00 | 26.79 | 24,111.00 | 123,082.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023479/0001209191-19-023479-index.htm |
| 2019-04-03 | Carole Ho | Chief Medical Officer | Sell | 8,688.00 | 26.29 | 228,407.52 | 123,982.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023479/0001209191-19-023479-index.htm |
| 2019-04-02 | Carole Ho | Chief Medical Officer | Sell | 9,445.00 | 25.29 | 238,864.05 | 132,670.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023479/0001209191-19-023479-index.htm |
| 2020-06-05 | DOUGLAS K BRATTON | 10% Share Holder | Sell | 1,922,855.00 | 25.75 | 49,513,516.25 | 13,644,881.00 | https://www.sec.gov/Archives/edgar/data/1714899/000089924320015779/0000899243-20-015779-index.htm |
| 2019-03-14 | Carole Ho | Chief Medical Officer | Sell | 500.00 | 25.01 | 12,505.00 | 142,115.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119020068/0001209191-19-020068-index.htm |
| 2019-01-02 | Carole Ho | Chief Medical Officer | Sell | 900.00 | 20.24 | 18,216.00 | 142,615.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119002289/0001209191-19-002289-index.htm |
| 2019-01-02 | Carole Ho | Chief Medical Officer | Sell | 4,875.00 | 19.43 | 94,721.25 | 143,515.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119002289/0001209191-19-002289-index.htm |
| 2018-12-03 | Carole Ho | Chief Medical Officer | Sell | 400.00 | 19.16 | 7,664.00 | 148,390.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919118061334/0001209191-18-061334-index.htm |
| 2018-12-03 | Carole Ho | Chief Medical Officer | Sell | 17,100.00 | 18.43 | 315,170.10 | 148,790.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919118061334/0001209191-18-061334-index.htm |
| 2020-02-26 | DOUGLAS K BRATTON | 10% Share Holder | Sell | 3,894,764.00 | 20.25 | 78,868,971.00 | 15,567,736.00 | https://www.sec.gov/Archives/edgar/data/1714899/000089924320006252/0000899243-20-006252-index.htm |
| 2019-03-04 | Carole Ho | Chief Medical Officer | Sell | 4,263.00 | 21.87 | 93,231.81 | 1,600.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119016941/0001209191-19-016941-index.htm |
| 2020-09-10 | Carole Ho | Chief Medical Officer | Sell | 3,689.00 | 31.00 | 114,359.00 | 165,141.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919120050357/0001209191-20-050357-index.htm |
| 2018-11-15 | Carole Ho | Chief Medical Officer | Sell | 17,500.00 | 18.07 | 316,156.75 | 165,890.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919118059267/0001209191-18-059267-index.htm |
| 2020-10-08 | Carole Ho | Chief Medical Officer | Sell | 22,906.00 | 40.12 | 918,988.72 | 166,617.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919120054727/0001209191-20-054727-index.htm |
| 2020-10-09 | Carole Ho | Chief Medical Officer | Sell | 19,535.00 | 41.51 | 810,897.85 | 166,617.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919120054727/0001209191-20-054727-index.htm |
| 2020-10-09 | Carole Ho | Chief Medical Officer | Sell | 10,465.00 | 40.68 | 425,716.20 | 186,152.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919120054727/0001209191-20-054727-index.htm |
| 2020-10-08 | Carole Ho | Chief Medical Officer | Buy | 22,906.00 | 5.28 | 120,943.68 | 189,523.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919120054727/0001209191-20-054727-index.htm |
| 2019-03-01 | Carole Ho | Chief Medical Officer | Sell | 3,824.00 | 22.17 | 84,778.08 | 1,951.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119016941/0001209191-19-016941-index.htm |
| 2020-10-09 | Carole Ho | Chief Medical Officer | Buy | 30,000.00 | 5.28 | 158,400.00 | 196,617.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919120054727/0001209191-20-054727-index.htm |
| 2019-05-09 | Carole Ho | Chief Medical Officer | Sell | 2,453.00 | 22.86 | 56,075.58 | 200.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119029053/0001209191-19-029053-index.htm |
| 2020-03-30 | Ryan J. Watts | President and CEO | Sell | 4,807.00 | 19.48 | 93,640.36 | 22,013.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919120022238/0001209191-20-022238-index.htm |
| 2019-08-20 | Alexander O. Schuth | COO and Secretary | Buy | 5,643.00 | 22,685.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119047187/0001209191-19-047187-index.htm | ||
| 2019-12-04 | Ryan J. Watts | President and CEO | Sell | 18,755.00 | 18.00 | 337,590.00 | 2,429,304.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119059302/0001209191-19-059302-index.htm |
| 2019-12-03 | Ryan J. Watts | President and CEO | Sell | 2,513.00 | 18.02 | 45,284.26 | 2,448,059.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119059302/0001209191-19-059302-index.htm |
| 2019-11-25 | Ryan J. Watts | President and CEO | Sell | 42,185.00 | 18.02 | 760,173.70 | 2,450,572.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119058172/0001209191-19-058172-index.htm |
| 2019-11-22 | Ryan J. Watts | President and CEO | Sell | 1,300.00 | 18.00 | 23,400.00 | 2,492,757.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119058172/0001209191-19-058172-index.htm |
| 2019-09-05 | Ryan J. Watts | President and CEO | Sell | 4,847.00 | 18.09 | 87,682.23 | 2,494,057.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119048640/0001209191-19-048640-index.htm |
| 2019-09-03 | Ryan J. Watts | President and CEO | Sell | 3,734.00 | 18.00 | 67,212.00 | 2,498,904.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119048640/0001209191-19-048640-index.htm |
| 2019-07-01 | Ryan J. Watts | President and CEO | Sell | 18,333.00 | 20.76 | 380,593.08 | 2,502,638.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119041176/0001209191-19-041176-index.htm |
| 2019-05-10 | Carole Ho | Chief Medical Officer | Buy | 2,546.00 | 5.28 | 13,442.88 | 2,546.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119029053/0001209191-19-029053-index.htm |
| 2019-06-03 | Ryan J. Watts | President and CEO | Sell | 18,333.00 | 19.07 | 349,610.31 | 2,560,971.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119034830/0001209191-19-034830-index.htm |
| 2019-05-03 | Ryan J. Watts | President and CEO | Sell | 6,111.00 | 24.49 | 149,658.39 | 2,579,304.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119027547/0001209191-19-027547-index.htm |
| 2019-10-23 | Alexander O. Schuth | COO and Secretary | Buy | 5,129.00 | 5.28 | 27,081.12 | 25,839.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119054152/0001209191-19-054152-index.htm |
| 2019-12-03 | Alexander O. Schuth | COO and Secretary | Sell | 711.00 | 18.01 | 12,805.11 | 25,839.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119059343/0001209191-19-059343-index.htm |
| 2019-12-04 | Alexander O. Schuth | COO and Secretary | Sell | 3,121.00 | 18.00 | 56,178.00 | 25,839.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119059343/0001209191-19-059343-index.htm |
| 2019-05-02 | Ryan J. Watts | President and CEO | Sell | 6,111.00 | 24.03 | 146,847.33 | 2,585,415.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119027547/0001209191-19-027547-index.htm |
| 2019-05-01 | Ryan J. Watts | President and CEO | Sell | 6,112.00 | 24.09 | 147,238.08 | 2,591,526.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119027547/0001209191-19-027547-index.htm |
| 2019-04-03 | Ryan J. Watts | President and CEO | Sell | 500.00 | 26.77 | 13,385.00 | 2,597,638.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023478/0001209191-19-023478-index.htm |
| 2019-04-03 | Ryan J. Watts | President and CEO | Sell | 5,641.00 | 26.28 | 148,245.48 | 2,598,138.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023478/0001209191-19-023478-index.htm |
| 2019-04-02 | Ryan J. Watts | President and CEO | Sell | 2,942.00 | 25.17 | 74,050.14 | 2,603,779.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023478/0001209191-19-023478-index.htm |
| 2019-04-02 | Ryan J. Watts | President and CEO | Sell | 3,200.00 | 24.52 | 78,464.00 | 2,606,721.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023478/0001209191-19-023478-index.htm |
| 2019-04-01 | Ryan J. Watts | President and CEO | Sell | 6,050.00 | 23.91 | 144,655.50 | 2,609,921.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023478/0001209191-19-023478-index.htm |
| 2019-05-08 | Carole Ho | Chief Medical Officer | Buy | 2,613.00 | 5.28 | 13,796.64 | 2,613.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119029053/0001209191-19-029053-index.htm |
| 2019-03-05 | Ryan J. Watts | President and CEO | Sell | 6,141.00 | 21.97 | 134,917.77 | 2,615,971.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119016931/0001209191-19-016931-index.htm |
| 2019-03-04 | Ryan J. Watts | President and CEO | Sell | 1,700.00 | 22.83 | 38,811.00 | 2,622,112.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119016931/0001209191-19-016931-index.htm |
| 2019-03-04 | Ryan J. Watts | President and CEO | Sell | 4,442.00 | 21.87 | 97,146.54 | 2,623,812.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119016931/0001209191-19-016931-index.htm |
| 2019-03-01 | Ryan J. Watts | President and CEO | Sell | 2,050.00 | 22.91 | 46,965.50 | 2,628,254.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119016931/0001209191-19-016931-index.htm |
| 2019-03-01 | Ryan J. Watts | President and CEO | Sell | 4,000.00 | 22.19 | 88,760.00 | 2,630,304.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119016931/0001209191-19-016931-index.htm |
| 2019-02-05 | Ryan J. Watts | President and CEO | Sell | 8,230.00 | 18.83 | 154,970.90 | 2,634,304.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119007483/0001209191-19-007483-index.htm |
| 2019-02-04 | Ryan J. Watts | President and CEO | Sell | 854.00 | 19.12 | 16,328.48 | 2,642,534.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119007483/0001209191-19-007483-index.htm |
| 2019-02-04 | Ryan J. Watts | President and CEO | Sell | 3,200.00 | 18.49 | 59,168.00 | 2,643,388.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119007483/0001209191-19-007483-index.htm |
| 2019-02-01 | Ryan J. Watts | President and CEO | Sell | 6,050.00 | 18.65 | 112,832.50 | 2,646,588.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119007483/0001209191-19-007483-index.htm |
| 2019-01-04 | Ryan J. Watts | President and CEO | Sell | 4,933.00 | 20.02 | 98,758.66 | 2,652,638.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119002284/0001209191-19-002284-index.htm |
| 2019-05-09 | Carole Ho | Chief Medical Officer | Buy | 2,653.00 | 5.28 | 14,007.84 | 2,653.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119029053/0001209191-19-029053-index.htm |
| 2019-12-03 | Alexander O. Schuth | COO and Secretary | Buy | 711.00 | 5.28 | 3,754.08 | 26,550.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119059343/0001209191-19-059343-index.htm |
| 2019-01-04 | Ryan J. Watts | President and CEO | Sell | 1,300.00 | 19.18 | 24,934.00 | 2,657,571.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119002284/0001209191-19-002284-index.htm |
| 2019-01-03 | Ryan J. Watts | President and CEO | Sell | 6,050.00 | 18.89 | 114,284.50 | 2,658,871.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119002284/0001209191-19-002284-index.htm |
| 2019-01-02 | Ryan J. Watts | President and CEO | Sell | 1,000.00 | 20.24 | 20,240.00 | 2,664,921.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119002284/0001209191-19-002284-index.htm |
| 2019-01-02 | Ryan J. Watts | President and CEO | Sell | 5,050.00 | 19.42 | 98,071.00 | 2,665,921.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119002284/0001209191-19-002284-index.htm |
| 2018-12-03 | Ryan J. Watts | President and CEO | Sell | 400.00 | 19.16 | 7,664.00 | 2,670,971.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919118061329/0001209191-18-061329-index.htm |
| 2018-12-03 | Ryan J. Watts | President and CEO | Sell | 17,933.00 | 18.42 | 330,273.85 | 2,671,371.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919118061329/0001209191-18-061329-index.htm |
| 2018-11-15 | Ryan J. Watts | President and CEO | Sell | 13,588.00 | 18.12 | 246,236.30 | 2,729,304.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919118058797/0001209191-18-058797-index.htm |
| 2020-06-16 | Marc Tessier-Lavigne | Director | Sell | 400,000.00 | 26.10 | 10,440,000.00 | 2,739,043.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919120037764/0001209191-20-037764-index.htm |
| 2018-11-13 | Ryan J. Watts | President and CEO | Sell | 4,746.00 | 18.00 | 85,428.00 | 2,742,892.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919118058797/0001209191-18-058797-index.htm |
| 2019-01-03 | Carole Ho | Chief Medical Officer | Sell | 2,777.00 | 18.90 | 52,485.30 | 2,777.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119002289/0001209191-19-002289-index.htm |
| 2019-01-04 | Carole Ho | Chief Medical Officer | Sell | 4,450.00 | 20.03 | 89,133.50 | 2,777.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119002289/0001209191-19-002289-index.htm |
| 2020-03-30 | Carole Ho | Chief Medical Officer | Sell | 1,428.00 | 19.48 | 27,817.44 | 2,822.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919120022239/0001209191-20-022239-index.htm |
| 2020-03-30 | Alexander O. Schuth | COO and Secretary | Sell | 1,427.00 | 19.49 | 27,812.23 | 28,662.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919120022240/0001209191-20-022240-index.htm |
| 2019-12-04 | Alexander O. Schuth | COO and Secretary | Buy | 3,121.00 | 5.28 | 16,478.88 | 28,960.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119059343/0001209191-19-059343-index.htm |
| 2019-04-02 | Carole Ho | Chief Medical Officer | Sell | 2,800.00 | 24.51 | 68,628.00 | 3,335.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023479/0001209191-19-023479-index.htm |
| 2019-12-20 | Carole Ho | Chief Medical Officer | Sell | 860.00 | 20.00 | 17,200.00 | 3,464.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119061843/0001209191-19-061843-index.htm |
| 2019-02-04 | Carole Ho | Chief Medical Officer | Buy | 3,139.00 | 5.28 | 16,573.92 | 3,869.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119007484/0001209191-19-007484-index.htm |
| 2019-06-10 | Carole Ho | Chief Medical Officer | Buy | 3,906.00 | 5.28 | 20,623.68 | 3,906.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119036499/0001209191-19-036499-index.htm |
| 2019-07-08 | Carole Ho | Chief Medical Officer | Sell | 2,604.00 | 19.93 | 51,897.72 | 4,081.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119041708/0001209191-19-041708-index.htm |
| 2019-07-08 | Carole Ho | Chief Medical Officer | Sell | 3,907.00 | 20.55 | 80,288.85 | 4,081.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119041708/0001209191-19-041708-index.htm |
| 2019-12-19 | Carole Ho | Chief Medical Officer | Sell | 2,566.00 | 20.00 | 51,320.00 | 4,324.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119061843/0001209191-19-061843-index.htm |
| 2020-06-30 | DOUGLAS K BRATTON | 10% Share Holder | Sell | 200.00 | 24.34 | 4,868.00 | 448,035.00 | https://www.sec.gov/Archives/edgar/data/1714899/000089924320018024/0000899243-20-018024-index.htm |
| 2020-06-30 | DOUGLAS K BRATTON | 10% Share Holder | Sell | 45,145.00 | 24.01 | 1,083,732.81 | 448,235.00 | https://www.sec.gov/Archives/edgar/data/1714899/000089924320018024/0000899243-20-018024-index.htm |
| 2020-06-29 | DOUGLAS K BRATTON | 10% Share Holder | Sell | 20,771.00 | 24.50 | 508,974.66 | 493,380.00 | https://www.sec.gov/Archives/edgar/data/1714899/000089924320018024/0000899243-20-018024-index.htm |
| 2019-03-14 | Carole Ho | Chief Medical Officer | Buy | 500.00 | 5.28 | 2,640.00 | 500.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119020068/0001209191-19-020068-index.htm |
| 2020-06-29 | DOUGLAS K BRATTON | 10% Share Holder | Sell | 61,807.00 | 23.84 | 1,473,398.53 | 514,151.00 | https://www.sec.gov/Archives/edgar/data/1714899/000089924320018024/0000899243-20-018024-index.htm |
| 2019-08-20 | Carole Ho | Chief Medical Officer | Buy | 5,643.00 | 52,518.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119047185/0001209191-19-047185-index.htm | ||
| 2020-06-26 | DOUGLAS K BRATTON | 10% Share Holder | Sell | 13,604.00 | 24.67 | 335,636.53 | 575,958.00 | https://www.sec.gov/Archives/edgar/data/1714899/000089924320018024/0000899243-20-018024-index.htm |
| 2019-02-01 | Carole Ho | Chief Medical Officer | Buy | 5,775.00 | 5.28 | 30,492.00 | 5,775.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119007484/0001209191-19-007484-index.htm |
| 2019-03-01 | Carole Ho | Chief Medical Officer | Buy | 5,775.00 | 5.28 | 30,492.00 | 5,775.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119016941/0001209191-19-016941-index.htm |
| 2019-04-01 | Carole Ho | Chief Medical Officer | Buy | 5,775.00 | 5.28 | 30,492.00 | 5,775.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023479/0001209191-19-023479-index.htm |
| 2019-12-04 | Alexander O. Schuth | COO and Secretary | Sell | 2,656.00 | 18.00 | 47,808.00 | 580,710.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119059343/0001209191-19-059343-index.htm |
| 2019-12-03 | Alexander O. Schuth | COO and Secretary | Sell | 1,012.00 | 18.01 | 18,226.12 | 583,366.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119059343/0001209191-19-059343-index.htm |
| 2019-11-26 | Alexander O. Schuth | COO and Secretary | Sell | 229.00 | 18.02 | 4,126.58 | 584,378.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119058147/0001209191-19-058147-index.htm |
| 2019-11-25 | Alexander O. Schuth | COO and Secretary | Sell | 14,125.00 | 18.02 | 254,532.50 | 584,607.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119058147/0001209191-19-058147-index.htm |
| 2019-03-05 | Carole Ho | Chief Medical Officer | Buy | 5,862.00 | 5.28 | 30,951.36 | 5,862.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119016941/0001209191-19-016941-index.htm |
| 2019-04-03 | Carole Ho | Chief Medical Officer | Sell | 5,862.00 | 5.28 | 30,951.36 | 5,862.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023479/0001209191-19-023479-index.htm |
| 2019-03-04 | Carole Ho | Chief Medical Officer | Buy | 5,863.00 | 5.28 | 30,956.64 | 5,863.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119016941/0001209191-19-016941-index.htm |
| 2020-06-26 | DOUGLAS K BRATTON | 10% Share Holder | Sell | 108,473.00 | 23.84 | 2,586,441.06 | 589,562.00 | https://www.sec.gov/Archives/edgar/data/1714899/000089924320018024/0000899243-20-018024-index.htm |
| 2019-11-22 | Alexander O. Schuth | COO and Secretary | Sell | 646.00 | 18.00 | 11,628.00 | 598,732.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119058147/0001209191-19-058147-index.htm |
| 2019-04-03 | Carole Ho | Chief Medical Officer | Sell | 5,262.00 | 26.27 | 138,232.74 | 600.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023479/0001209191-19-023479-index.htm |
| 2019-09-09 | Alexander O. Schuth | COO and Secretary | Sell | 7,500.00 | 18.16 | 136,200.00 | 610,089.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119049178/0001209191-19-049178-index.htm |
| 2019-04-02 | Carole Ho | Chief Medical Officer | Buy | 6,135.00 | 5.28 | 32,392.80 | 6,135.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119023479/0001209191-19-023479-index.htm |
| 2020-08-20 | Alexander O. Schuth | COO and Secretary | Buy | 5,643.00 | 616,516.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919120048174/0001209191-20-048174-index.htm | ||
| 2019-08-07 | Alexander O. Schuth | COO and Secretary | Sell | 7,500.00 | 18.81 | 141,075.00 | 617,589.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119045394/0001209191-19-045394-index.htm |
| 2019-07-08 | Alexander O. Schuth | COO and Secretary | Sell | 400.00 | 20.90 | 8,360.00 | 625,089.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119041710/0001209191-19-041710-index.htm |
| 2019-07-08 | Alexander O. Schuth | COO and Secretary | Sell | 7,100.00 | 20.25 | 143,775.00 | 625,489.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119041710/0001209191-19-041710-index.htm |
| 2019-06-10 | Alexander O. Schuth | COO and Secretary | Sell | 7,500.00 | 18.77 | 140,775.00 | 632,589.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119036500/0001209191-19-036500-index.htm |
| 2019-05-13 | Alexander O. Schuth | COO and Secretary | Sell | 2,500.00 | 21.09 | 52,725.00 | 640,089.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119029432/0001209191-19-029432-index.htm |
| 2019-05-10 | Alexander O. Schuth | COO and Secretary | Sell | 2,500.00 | 22.19 | 55,475.00 | 642,589.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119029432/0001209191-19-029432-index.htm |
| 2019-05-09 | Alexander O. Schuth | COO and Secretary | Sell | 2,500.00 | 22.86 | 57,150.00 | 645,089.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119029432/0001209191-19-029432-index.htm |
| 2019-04-11 | Alexander O. Schuth | COO and Secretary | Sell | 2,512.00 | 27.73 | 69,657.76 | 647,589.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119024390/0001209191-19-024390-index.htm |
| 2020-11-04 | David P Schenkein | Director | Sell | 10,000.00 | 50.18 | 501,830.00 | 65,000.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919120057336/0001209191-20-057336-index.htm |
| 2019-04-10 | Alexander O. Schuth | COO and Secretary | Sell | 2,513.00 | 28.26 | 71,017.38 | 650,101.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119024390/0001209191-19-024390-index.htm |
| 2019-04-09 | Alexander O. Schuth | COO and Secretary | Sell | 2,475.00 | 28.17 | 69,720.75 | 652,614.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119024390/0001209191-19-024390-index.htm |
| 2019-03-13 | Alexander O. Schuth | COO and Secretary | Sell | 1,512.00 | 24.33 | 36,786.96 | 655,089.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119019213/0001209191-19-019213-index.htm |
| 2019-03-13 | Alexander O. Schuth | COO and Secretary | Sell | 1,000.00 | 23.60 | 23,600.00 | 656,601.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119019213/0001209191-19-019213-index.htm |
| 2019-03-12 | Alexander O. Schuth | COO and Secretary | Sell | 2,513.00 | 22.40 | 56,291.20 | 657,601.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119019213/0001209191-19-019213-index.htm |
| 2019-03-11 | Alexander O. Schuth | COO and Secretary | Sell | 275.00 | 21.80 | 5,995.00 | 660,114.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119019213/0001209191-19-019213-index.htm |
| 2019-03-11 | Alexander O. Schuth | COO and Secretary | Sell | 2,200.00 | 21.20 | 46,640.00 | 660,389.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119019213/0001209191-19-019213-index.htm |
| 2019-02-12 | Alexander O. Schuth | COO and Secretary | Sell | 1,700.00 | 20.24 | 34,408.00 | 662,589.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119009482/0001209191-19-009482-index.htm |
| 2019-02-12 | Alexander O. Schuth | COO and Secretary | Sell | 800.00 | 19.73 | 15,784.00 | 664,289.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119009482/0001209191-19-009482-index.htm |
| 2019-02-11 | Alexander O. Schuth | COO and Secretary | Sell | 1,266.00 | 19.35 | 24,497.10 | 665,089.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119009482/0001209191-19-009482-index.htm |
| 2019-02-11 | Alexander O. Schuth | COO and Secretary | Sell | 1,234.00 | 18.74 | 23,125.16 | 666,355.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119009482/0001209191-19-009482-index.htm |
| 2019-02-08 | Alexander O. Schuth | COO and Secretary | Sell | 2,500.00 | 18.11 | 45,275.00 | 667,589.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119009482/0001209191-19-009482-index.htm |
| 2019-07-08 | Carole Ho | Chief Medical Officer | Buy | 2,604.00 | 5.28 | 13,749.12 | 6,685.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119041708/0001209191-19-041708-index.htm |
| 2019-01-11 | Alexander O. Schuth | COO and Secretary | Sell | 2,500.00 | 20.80 | 52,000.00 | 670,089.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119003443/0001209191-19-003443-index.htm |
| 2019-01-10 | Alexander O. Schuth | COO and Secretary | Sell | 2,500.00 | 19.99 | 49,975.00 | 672,589.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119003443/0001209191-19-003443-index.htm |
| 2019-01-09 | Alexander O. Schuth | COO and Secretary | Sell | 2,500.00 | 20.31 | 50,775.00 | 675,089.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119003443/0001209191-19-003443-index.htm |
| 2018-12-12 | Alexander O. Schuth | COO and Secretary | Sell | 2,500.00 | 20.80 | 52,000.00 | 677,589.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919118062266/0001209191-18-062266-index.htm |
| 2018-12-11 | Alexander O. Schuth | COO and Secretary | Sell | 2,500.00 | 20.22 | 50,550.00 | 680,089.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919118062266/0001209191-18-062266-index.htm |
| 2018-12-10 | Alexander O. Schuth | COO and Secretary | Sell | 2,500.00 | 20.18 | 50,450.00 | 682,589.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919118062266/0001209191-18-062266-index.htm |
| 2020-06-23 | DOUGLAS K BRATTON | 10% Share Holder | Sell | 3,247.00 | 26.19 | 85,027.89 | 698,035.00 | https://www.sec.gov/Archives/edgar/data/1714899/000089924320017498/0000899243-20-017498-index.htm |
| 2020-06-23 | DOUGLAS K BRATTON | 10% Share Holder | Sell | 16,777.00 | 25.69 | 430,940.73 | 701,282.00 | https://www.sec.gov/Archives/edgar/data/1714899/000089924320017498/0000899243-20-017498-index.htm |
| 2019-06-10 | Carole Ho | Chief Medical Officer | Buy | 711.00 | 5.28 | 3,754.08 | 711.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119036499/0001209191-19-036499-index.htm |
| 2020-06-22 | DOUGLAS K BRATTON | 10% Share Holder | Sell | 24,683.00 | 25.12 | 619,960.44 | 718,059.00 | https://www.sec.gov/Archives/edgar/data/1714899/000089924320017498/0000899243-20-017498-index.htm |
| 2019-01-04 | Carole Ho | Chief Medical Officer | Sell | 1,500.00 | 19.30 | 28,950.00 | 7,227.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119002289/0001209191-19-002289-index.htm |
| 2019-02-04 | Carole Ho | Chief Medical Officer | Buy | 730.00 | 5.28 | 3,854.40 | 730.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119007484/0001209191-19-007484-index.htm |
| 2020-06-22 | DOUGLAS K BRATTON | 10% Share Holder | Sell | 65,373.00 | 24.66 | 1,611,941.28 | 742,742.00 | https://www.sec.gov/Archives/edgar/data/1714899/000089924320017498/0000899243-20-017498-index.htm |
| 2019-02-04 | Carole Ho | Chief Medical Officer | Sell | 3,100.00 | 18.49 | 57,319.00 | 769.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119007484/0001209191-19-007484-index.htm |
| 2019-02-05 | Carole Ho | Chief Medical Officer | Buy | 7,856.00 | 5.28 | 41,479.68 | 7,856.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119007484/0001209191-19-007484-index.htm |
| 2019-07-08 | Carole Ho | Chief Medical Officer | Buy | 3,907.00 | 5.28 | 20,628.96 | 7,988.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119041708/0001209191-19-041708-index.htm |
| 2019-07-08 | Carole Ho | Chief Medical Officer | Sell | 1,100.00 | 20.88 | 22,968.00 | 79,934.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119041708/0001209191-19-041708-index.htm |
| 2020-06-19 | DOUGLAS K BRATTON | 10% Share Holder | Sell | 62,439.00 | 25.00 | 1,560,850.12 | 808,115.00 | https://www.sec.gov/Archives/edgar/data/1714899/000089924320017498/0000899243-20-017498-index.htm |
| 2019-07-08 | Carole Ho | Chief Medical Officer | Sell | 9,889.00 | 20.21 | 199,856.69 | 81,034.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119041708/0001209191-19-041708-index.htm |
| 2020-08-20 | Carole Ho | Chief Medical Officer | Buy | 5,643.00 | 8,465.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919120048175/0001209191-20-048175-index.htm | ||
| 2019-01-03 | Carole Ho | Chief Medical Officer | Buy | 5,775.00 | 5.28 | 30,492.00 | 8,552.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119002289/0001209191-19-002289-index.htm |
| 2020-06-19 | DOUGLAS K BRATTON | 10% Share Holder | Sell | 82,481.00 | 24.20 | 1,995,652.54 | 870,554.00 | https://www.sec.gov/Archives/edgar/data/1714899/000089924320017498/0000899243-20-017498-index.htm |
| 2019-01-04 | Carole Ho | Chief Medical Officer | Buy | 5,950.00 | 5.28 | 31,416.00 | 8,727.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119002289/0001209191-19-002289-index.htm |
| 2019-06-10 | Carole Ho | Chief Medical Officer | Sell | 12,883.00 | 18.78 | 241,942.74 | 90,923.00 | https://www.sec.gov/Archives/edgar/data/1714899/000120919119036499/0001209191-19-036499-index.htm |